FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
Twist Bioscience Corporation (NASDAQ: TWST) reported Q2 EPS of ($0.85), $0.10 worse than the analyst estimate of ($0.75). Revenue for the quarter came in at $19.3 million versus the consensus estimate of $18.27 million.
In the midst of the global pandemic, we introduced our methylation product for next-generation... More

